Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pharming (PHAR) Shares Outstanding (Weighted Average) (2019 - 2025)

Historic Shares Outstanding (Weighted Average) for Pharming (PHAR) over the last 6 years, with Q4 2024 value amounting to $5.0.

  • Pharming's Shares Outstanding (Weighted Average) changed N/A to $5.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $5.0, marking a year-over-year change of. This contributed to the annual value of $5.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Pharming reported Shares Outstanding (Weighted Average) of $5.0 as of Q4 2024.
  • In the past 5 years, Pharming's Shares Outstanding (Weighted Average) registered a high of $60.81 during Q4 2020, and its lowest value of $2.0 during Q2 2023.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $22.83, with a median of $22.0 in 2021.
  • As far as peak fluctuations go, Pharming's Shares Outstanding (Weighted Average) skyrocketed by 9545.45% in 2022, and later plummeted by 9310.34% in 2023.
  • Over the past 5 years, Pharming's Shares Outstanding (Weighted Average) (Quarter) stood at $60.81 in 2020, then crashed by 60.49% to $24.02 in 2021, then decreased by 12.59% to $21.0 in 2022, then plummeted by 76.19% to $5.0 in 2023, then changed by 0.0% to $5.0 in 2024.
  • Its last three reported values are $5.0 in Q4 2024, $5.0 for Q3 2023, and $2.0 during Q2 2023.